According to Google DeepMind, its C2S-Scale 27B model, built on the Gemma open model family, identified a new potential pathway by which cancer cells hide from the immune system, and this hypothesis was validated in lab experiments with scientists at Yale University. Source: Google DeepMind (X, Oct 17, 2025). For trading context, the source announces an AI-driven biological finding and lab validation but provides no details on datasets, commercialization, clinical timelines, or any blockchain, token, or on-chain integration, indicating no direct, stated crypto market linkage in this release. Source: Google DeepMind (X, Oct 17, 2025).

According to Google DeepMind (@GoogleDeepMind), AlphaFold 3 has successfully predicted millions of molecular interactions over the past year, accelerating research in crop immunity and bacterial resistance. This AI advancement, in collaboration with Isomorphic Labs, is driving significant biotech innovation, which could influence tokenized biotech projects and related AI-crypto assets as investor interest in AI-driven solutions grows (source: @GoogleDeepMind, May 8, 2025).